Incongruence in treatment decision making is associated with lower health-related quality of life among prostate cancer survivors: results from the PiCTure study

Drummond, Frances J.; Gavin, Anna; Sharp, Linda

doi:10.1007/s00520-017-3994-z

Cited by 8 publications

(18 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…While the proportion of patients who perceive that they were involved in TDM at their preferred level has varied widely in past studies (31‐97%), our results are very similar to the mean concordance rates of between 58% and 61% reported for cancer treatment decisions in systematic reviews . They also align with a recent study that found a concordance rate of 58% among a sample of over 3000 men with prostate cancer, indicating that despite increased recognition of the need to meet patients preferences for involvement in TDM, a persistent gap in care remains. Given the significant benefits associated with ensuring that patients are involved in decisions to their preferred extent, including increased satisfaction with decision making and reduced decisional regret, there is a need to further understand and address this important gap in cancer care.…”

Section: Discussionsupporting

confidence: 87%

Getting the right fit: Convergence between preferred and perceived involvement in treatment decision making among medical oncology outpatients

Mansfield

Bryant

Carey

et al. 2018

Health Science Reports

View full text Add to dashboard Cite

Background and AimsWhile cancer patients' preferences for their level of involvement in treatment decision making (TDM) vary, previous research indicates a large proportion of patients are not experiencing TDM that meets their preferences. Evidence is needed to identify the characteristics of cancer patients who are less likely to report experiencing their preferred level of involvement in TDM, so that appropriate decision‐making support can be provided to them. We examined in a sample of medical oncology outpatients (1) the level of agreement between preferred and perceived involvement in TDM and (2) demographic, psychological, disease, and treatment characteristics associated with having unmet preferences for involvement in TDM.Methods and ResultsCancer patients from three medical oncology treatment centers in Australia completed surveys assessing demographic, disease and treatment variables, psychological distress, and preferred and perceived involvement in TDM. Data were collected between February 2013 and December 2014. Factors associated with having unmet TDM preferences were examined using logistic regression. There were 355 patients included in the analysis (75% response rate). The mean age (±SD) of the participants was 61 (±12), and 45% were male. Overall, 60% of participants reported that their preferences for involvement in TDM were met. No demographic, psychological, disease, or treatment characteristics were significantly associated with an increased probability of not having TDM preferences met.ConclusionsIn line with previous research, a large proportion (40%) of patients reported TDM experiences that were not in alignment with their preferences. Future research should explore additional characteristics that are associated with a lower likelihood of having TDM preferences met.

show abstract

Section: Discussionsupporting

confidence: 87%

Getting the right fit: Convergence between preferred and perceived involvement in treatment decision making among medical oncology outpatients

Mansfield

Bryant

Carey

et al. 2018

Health Science Reports

View full text Add to dashboard Cite

show abstract

“…Indeed, requiring patients to take more TDM responsibility than they desire may be to disempower them. Recent evidence indicates incongruence between preferred and actual roles in TDM led to significantly lower health-related quality of life amongst PCa survivors, especially amongst men who reported more involvement than desired [32].…”

Section: Discussionmentioning

confidence: 99%

‘Very difficult for an ordinary guy’: Factors influencing the quality of treatment decision-making amongst men diagnosed with localised and locally advanced prostate cancer: Findings from a UK-wide mixed methods study

Wagland

Nayoan

Matheson

et al. 2019

Patient Education and Counseling

View full text Add to dashboard Cite

show abstract

“…In several studies, decision preferences were also investigated in prostate cancer patients [8][9][10][11][12][13][14][15][16]. Preferences varied widely, but possible reasons for this observation were only investigated to a very limited extent.…”

Section: Introductionmentioning

confidence: 99%

The Treatment Decision-making Preferences of Patients with Prostate Cancer Should Be Recorded in Research and Clinical Routine: a Pooled Analysis of Four Survey Studies with 7169 Patients

et al. 2020

View full text Add to dashboard Cite

Different patients want to take different roles in the treatment decision-making process; these roles can be classified as passive, collaborative, and active. The aim of this study was to investigate the correlation between decision-making preferences among patients with prostate cancer and personal, disease-related, and structural factors. In four survey studies, we asked 7169 prostate cancer patients about their decision-making preferences using the Control Preferences Scale (CPS) and collected clinical, psychological, and quality-of-life measures. Most patients (62.2%) preferred collaborative decision-making, while 2322 (32.4%) preferred an active role, and only 391 (5.5%) preferred a passive role. Age (p < 0.001), data collection mode (p < 0.001), peer-to-peer support (p = 0.018), treatment status (p < 0.001), performed or planned radical prostatectomy (p < 0.001), metastatic disease (p = 0.001), and quality of life (p < 0.001) showed significant associations with patients’ preferred decision-making roles. Oncologic risk group, anxiety, and depression were not significant in the model. In particular, younger prostate cancer patients with higher quality of life completing an online survey want to play a more active role in treatment decision-making. Before treatment has started, patients tend to prefer collaborative decision-making. Few prostate cancer patients in Germany prefer a passive role. These patients are mostly older patients, patients with a metastatic disease, and patients who have opted for prostatectomy. Whether this finding reflects a generational effect or a tendency by age group and disease phase should be investigated. Further research is also needed to describe the causalities of these relationships. The CPS offers valuable information for personal counselling and should be applied in clinical routine. In a large group of patients with prostate cancer, we found that there is a strong desire for joint decision-making with the physician before the actual treatment. Especially younger men, men with active online behaviour, and men with a high quality of life want to be actively involved in therapy decision-making processes.

show abstract

Incongruence in treatment decision making is associated with lower health-related quality of life among prostate cancer survivors: results from the PiCTure study

Cited by 8 publications

References 43 publications

Getting the right fit: Convergence between preferred and perceived involvement in treatment decision making among medical oncology outpatients

Getting the right fit: Convergence between preferred and perceived involvement in treatment decision making among medical oncology outpatients

‘Very difficult for an ordinary guy’: Factors influencing the quality of treatment decision-making amongst men diagnosed with localised and locally advanced prostate cancer: Findings from a UK-wide mixed methods study

The Treatment Decision-making Preferences of Patients with Prostate Cancer Should Be Recorded in Research and Clinical Routine: a Pooled Analysis of Four Survey Studies with 7169 Patients

Contact Info

Product

Resources

About